SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001267602-19-000169
Filing Date
2019-11-05
Accepted
2019-11-05 16:39:32
Documents
78
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alim-9301910q.htm 10-Q 1497711
2 EXHIBIT 31.1 alimera-10xqexhibit31193019.htm EX-31.1 22235
3 EXHIBIT 31.2 alimera-10xqexhibit31293019.htm EX-31.2 21499
4 EXHIBIT 32.1 alimera-10xqexhibit32193019.htm EX-32.1 7878
  Complete submission text file 0001267602-19-000169.txt   7554393

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT alim-20190930.xml EX-101.INS 1652960
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alim-20190930.xsd EX-101.SCH 54189
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alim-20190930_cal.xml EX-101.CAL 94220
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alim-20190930_def.xml EX-101.DEF 270305
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alim-20190930_lab.xml EX-101.LAB 691626
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alim-20190930_pre.xml EX-101.PRE 433822
Mailing Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005
Business Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34703 | Film No.: 191193881
SIC: 2834 Pharmaceutical Preparations